ES2043632T3 - Un proceso para la preparacion de una composicion promotora de la proliferacion de lactobacillus bifidus. - Google Patents

Un proceso para la preparacion de una composicion promotora de la proliferacion de lactobacillus bifidus.

Info

Publication number
ES2043632T3
ES2043632T3 ES87115999T ES87115999T ES2043632T3 ES 2043632 T3 ES2043632 T3 ES 2043632T3 ES 87115999 T ES87115999 T ES 87115999T ES 87115999 T ES87115999 T ES 87115999T ES 2043632 T3 ES2043632 T3 ES 2043632T3
Authority
ES
Spain
Prior art keywords
lactobacillus bifidus
proliferation
promoting composition
preparation
xylooligosaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87115999T
Other languages
English (en)
Inventor
Yoshihide Suwa
Kunimasa Koga
Shigeaki Fujikawa
Masako Okazaki
Toshio Irie
Toshiyuki Nakada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ES2043632T3 publication Critical patent/ES2043632T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)

Abstract

SE PRESENTA UNA COMPOSICION PROMOTORA DE LA PROLIFERACION DE LACTOBACILLUS BIFIDUS QUE COMPRENDE UN XILOOLIGOSACARIDO QUE CONTIENE XILOBIOSA COMO PRINCIPAL COMPONENTE. EL XILOOLIGOSACARIDO SE OBTIENE TRATANDO ENZIMATICAMENTE O FISICOQUIMICAMENTE, O BIEN, XILANO, O BIEN, HEMICELULOSA DERIVADOS DE UNA FUENTE NATURAL. EL LACTOBACILLUS BIFIDUS, QUE ES UTIL PARA EL HOMBRE, ES IMPULSADO A PROLIFERAR EN EL INTESTINO POR EL XILOOLIGOSACARIDO QUE NO ES FACILMENTE ASIMILADO POR ESCHERICHIA COLI PERO ES FACILMENTE UTILIZADO POR LACTOBACILLUS BIFIDUS. EL XILOOLIGOSACARIDO ES VENTAJOSAMENTE ESTABLE CUANDO SE EXPONE A LOS ACIDOS O AL CALOR.
ES87115999T 1986-10-30 1987-10-30 Un proceso para la preparacion de una composicion promotora de la proliferacion de lactobacillus bifidus. Expired - Lifetime ES2043632T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61258757A JP2549638B2 (ja) 1986-10-30 1986-10-30 ビフイズス菌増殖促進組成物

Publications (1)

Publication Number Publication Date
ES2043632T3 true ES2043632T3 (es) 1994-01-01

Family

ID=17324661

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87115999T Expired - Lifetime ES2043632T3 (es) 1986-10-30 1987-10-30 Un proceso para la preparacion de una composicion promotora de la proliferacion de lactobacillus bifidus.

Country Status (7)

Country Link
US (1) US5939309A (es)
EP (1) EP0265970B1 (es)
JP (1) JP2549638B2 (es)
AT (1) ATE79401T1 (es)
CA (1) CA1300023C (es)
DE (1) DE3781087T2 (es)
ES (1) ES2043632T3 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000169376A (ja) 1998-12-10 2000-06-20 Suntory Ltd 高アンモニア血症治療剤
US6824646B2 (en) 1999-03-23 2004-11-30 Oji Paper Co., Ltd. Process for oxygen bleaching and enzyme treating lignocellulosic pulp with liquid treatment and recovery
CA2301371C (en) * 1999-03-23 2009-09-01 Oji Paper Co., Ltd. Process for bleaching lignocellulose pulp
US6942754B2 (en) 1999-03-23 2005-09-13 Oji Paper Co., Ltd. Process for producing xylooligosaccharide from lignocellulose pulp
JP2000300211A (ja) * 1999-04-21 2000-10-31 Risoo Erudesu:Kk 乳酸菌代謝生産物質配合健康食品組成物
DE10102525A1 (de) * 2001-01-20 2002-07-25 Nutrinova Gmbh Geschmacksverbesserung von Getränken
JP3405981B1 (ja) * 2002-06-26 2003-05-12 日本財経株式会社 酢酸セルロースの製造方法
SG129268A1 (en) * 2003-03-25 2007-02-26 Celjan Co Ltd Process for manufacturing cellulose molding, plantcomponent extracting apparatus, and process for producing cellulose acetate
US6936598B2 (en) * 2003-11-21 2005-08-30 Hill's Pet Nutrition, Inc. Composition and method
US7754677B2 (en) * 2003-12-05 2010-07-13 Hill's Pet Nutrition, Inc. Composition and method for reducing diarrhea in a mammal
EP1600062A1 (en) * 2004-05-25 2005-11-30 Cognis IP Management GmbH Oral and/or topical compositions comprising prebiotics and sterols
JP2006265170A (ja) * 2005-03-24 2006-10-05 Sanwa Denpun Kogyo Kk 難消化性の中性オリゴ糖のビフィズス菌増殖作用を増幅する薬剤、並びにかかる薬剤及び中性オリゴ糖を含有する組成物
AT503624B1 (de) * 2006-05-10 2008-08-15 Chemiefaser Lenzing Ag Verfahren zur herstellung von xylooligosacchariden
CN106912964A (zh) * 2015-12-25 2017-07-04 山东龙力生物科技股份有限公司 可溶性膳食纤维及其制备方法
BR112021024311A2 (pt) * 2019-07-01 2022-01-11 Nestle Sa Produção de serpina
CN110551231B (zh) * 2019-09-23 2021-06-15 桂林理工大学 一种羧甲基化木聚糖的制备方法、产品及其应用
EP3960772A1 (en) 2020-08-27 2022-03-02 Universidade do Minho Process for the production of xylan and xylan products from algae products and their uses
CN118044616A (zh) * 2023-09-05 2024-05-17 厦门大学 一种合生元及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61242592A (ja) * 1985-04-20 1986-10-28 Suntory Ltd キシラン分解物の製造方法

Also Published As

Publication number Publication date
EP0265970A2 (en) 1988-05-04
EP0265970B1 (en) 1992-08-12
JPS63112979A (ja) 1988-05-18
CA1300023C (en) 1992-05-05
EP0265970A3 (en) 1989-05-10
ATE79401T1 (de) 1992-08-15
JP2549638B2 (ja) 1996-10-30
US5939309A (en) 1999-08-17
DE3781087T2 (de) 1993-02-04
DE3781087D1 (de) 1992-09-17

Similar Documents

Publication Publication Date Title
ES2043632T3 (es) Un proceso para la preparacion de una composicion promotora de la proliferacion de lactobacillus bifidus.
MX169258B (es) Procedimiento para la preparacion de una fibra de vidrio resistente a alcalis
BRPI0511047A (pt) processos para a preparação de extratos vegetais e composições alimentìcias para animais de estimação
ES2147303T3 (es) Procedimiento de eliminacion de grupos de acido hexenuronico en la pasta de celulosa mediante tratamiento termico.
BR9812631A (pt) Tetraidro prostaglandinas substituìdas por c16-c20 aromáticos úteis como agonistas de fp
BR9908754A (pt) Composições liofilizada e lìquida de polinucleotìdeo e farmacêutica, processos para tratar um paciente mamìfero e para preparar uma composição liofilizada de polinucleotìdeo, produto liofilizado de polinucleotìdeo, e, processo para liofilizar uma composição de polinucleotìdeo
BR0314996A (pt) Composição, composição farmaceuticamente aceitável, método para produzir a composição, métodos para estabilizar a exendina-4 (1-39) ou uma sua variante, derivado ou análogo contra a degradação, antes, durante ou após o uso pretendido, para tratar doenças, para tratar de estados de doenças associados com nìveis elevados de glicose do sangue, para a regulação dos nìveis de glicose do sangue, para a regulação do esvaziamento gástrico, para estimular a liberação de insulina em um mamìfero para reduzir o nìvel de glicose do sangue em um mamìfero, para reduzir o nìvel de lipìdeos plasmáticos em um mamìfero, para reduzir a mortalidade e a morbidez após o infarto miocárdico em um mamìfero, para estimular a liberação de insulina em um mamìfero, e para produzir uma exendina (1-39) estabilizada, e, exendina (1-39) estabilizada
BR0208375A (pt) Composições de baixa resposta glicêmica
ES2017820A6 (es) Procedimiento de preparacion de un derivado de carboxamida.
BR8802852A (pt) Processo para a preparacao de compostos,processo para a preparacao de uma composicao,processo e composicoes para combater ou impedir uma infestacao das plantas
SE8702616D0 (sv) Sett vid blekning
MX170533B (es) Procedimiento para el escabeche o adobo de un producto carnico
KR880003620A (ko) 치료용 합성물 및 치료법(Therapeutic Composition and Method)
ES2052761T3 (es) Nuevos esteres del acido androstano 17-carboxilico, procedimiento para su preparacion y medicamento que los contiene.
ES2032339T3 (es) Procedimiento para preparar nuevos compuestos de indolilpiperidina.
FI102718B1 (fi) Menetelmä aspartaamiin perustuvan palasokerin kaltaisen makeutusaineen valmistamiseksi
BR8806062A (pt) Processo para a preparacao de uma composicao concentrada estavel,bombeavel e despejavel,processo para a preparacao de uma composicao amaciante de tecidos,composicao concentrada,e composicao para tratamento de texteis
KR870003790A (ko) 인간 트롬빈제제의 가열처리방법
BR9805538A (pt) Ferro-succinilcaseìna, processo para a preparação de ferro-succinilcaseìna, complexo férrico succinilado de caseìna alimentar, composição farmacêutica para o tratamento terapêutico de estados patológicos derivados de carência de ferro e uso do complexo férrico de caseìna alimentar succinilada.
ES2091319T3 (es) Proceso para preparar pasta kraft.
BR8606775A (pt) Processo de tratamento e para alvejar polpa kraft
PT94685A (pt) Processo para a preparacao de 2-imidazolinas substituidas e de composicoes farmaceuticas que as contem
ES2043062T3 (es) Procedimiento de preparacion de una composicion farmaceutica y/o dietetica.
ES2035102T3 (es) Compuestos que contienen hierro biodisponible, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
Van Lith et al. Plasma esterase-1 (ES-1) activity is increased in rats fed high-fat diets

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 265970

Country of ref document: ES